Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Steven Wagner

Vascular & Interventional Radiology Doylestown, PA Medical Doctor

NPI 1659366896 CMS profile 1122195

595 W State St, Doylestown, PA 18901

Open in the dashboard

General payments

$37,457

126 records reported · program years 2019–2025

Research payments

$400,331

Paid to them · 157 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Steven Wagner of Doylestown, PA is reported in the CMS Open Payments database as having received $37,457 across 126 general payments and $400,331 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

14 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,769 23
2025 Research $37,680 23
2024 General $1,614 24
2024 Research $10,730 16
2023 General $4,705 14
2023 Research $13,400 11
2022 General $885 12
2022 Research $17,853 20
2021 General $1,918 25
2021 Research $56,250 28
2020 General $10,614 11
2020 Research $131,775 28
2019 General $15,951 17
2019 Research $132,643 31

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Steven Wagner
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Steven Wagner were reported at $1,769. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Steven Wagner Vascular & Interventional Radiology median Middle half National median
2019 $15,951 $422 $125–$1,555 $163
2020 $10,614 $200 $68–$652 $114
2021 $1,918 $280 $99–$866 $132
2022 $885 $433 $137–$1,497 $149
2023 $4,705 $506 $152–$2,019 $160
2024 $1,614 $556 $175–$1,930 $164
2025 $1,769 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Genentech, Inc. $25,781 8 payments
  2. Siemens Medical Solutions USA, Inc. $4,274 6 payments
  3. Canon Medical Systems USA, Inc. $1,314 11 payments
  4. Inari Medical, Inc. $1,093 17 payments
  5. Sirtex Medical Inc $975 11 payments
  6. Penumbra, Inc. $839 7 payments
  7. Boston Scientific Corporation $838 16 payments
  8. Galvanize Therapeutics, Inc $524 7 payments
  9. AngioDynamics, Inc. $353 9 payments
  10. Medtronic, Inc. $309 5 payments
  11. Other $1,158 29 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $29,631 9 payments
  2. Food and Beverage $6,669 110 payments
  3. Travel and Lodging $1,031 6 payments
  4. Entertainment $125 1 payment
Products named General payments · program years 2019–2025
  1. Avastin $25,781 8 payments
  2. TECENTRIQ $25,781 8 payments
  3. Non-Covered Product $10,500 4 payments
  4. FLOWTRIEVER CATHETER, S $1,413 23 payments
  5. INTERVENTIONAL ANGIOGRAPHY SYSTEM $1,095 10 payments
  6. CT THROMBECTOMY SYSTEM KIT $867 15 payments
  7. SIR-Spheres Microspheres $847 10 payments
  8. Indigo System $809 6 payments
  9. ALIYA SYSTEM $524 7 payments
  10. TheraSphere Y90 Glass Microspheres 10 GBq $303 4 payments
  11. Other $2,829 66 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Regeneron Pharmaceuticals, Inc. $348,415 141 payments
  2. Amgen Inc. $24,405 3 payments
  3. Genentech, Inc. $18,844 5 payments
  4. Celgene Corporation $6,563 1 payment
  5. Hexal AG $2,105 7 payments

Billing to Medicare

Part B · data year 2024 · 147 billing codes

Paid by Medicare

$86,689

Medicare's payments for the services billed

Medicare patients

1,760

Average age 73

Services billed

2,424

1,387 women, 373 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 72%
Arthritis 49%
Osteoporosis 40%
Diabetes 31%
Ischemic heart disease 27%
Chronic kidney disease 26%
Depression 22%
COPD 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

283 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record